Medicines authorised in Romania

Rystiggo

Rystiggo is a medicine containing Rozanolixizumab, listed in the Romanian national register of medicines for human use with 4 presentations.

General information from the official register, not medical advice. Anpheros does not diagnose and does not recommend medicines. Read the package leaflet and ask your doctor or pharmacist before taking any medicine.

At a glance

Active substance
ROZANOLIXIZUMABUM
ATC code
L04AL02 Antineoplastic and immunomodulating agents
Therapeutic action
IMUNOSUPRESOARE
Prescription
Prescription required (register code PR)
Marketing authorisation holder
UCB PHARMA S.A. - BELGIA
Manufacturer
UCB PHARMA S.A. - BELGIA
Pharmaceutical form
SOL. INJ.

Presentations and codes

CIM is the code of each pack in the Romanian register; the Anpheros app saves it when it recognises the box.

CIM codeFormStrengthPackPrescriptionAuthorisationShelf life
W70053001SOL. INJ.140mg/mlCutie cu 1 flac. x 2 ml sol. inj.PR1780/2024/012 ani
W70053002SOL. INJ.140mg/mlCutie cu 1 flac. x 3 ml sol. inj.PR1780/2024/022 ani
W70053003SOL. INJ.140mg/mlCutie cu 1 flac. x 4 ml sol. inj.PR1780/2024/032 ani
W70053004SOL. INJ.140mg/mlCutie cu 1 flac. x 6 ml sol. inj.PR1780/2024/042 ani

What it is used for

The official indications for Rozanolixizumab, quoted from the European Medicines Agency and the US FDA, are on Rozanolixizumab in Anpheros Search.

The package leaflet and the summary of product characteristics are published by ANMDMR: search for “Rystiggo” in the national register.

Scan the box in Anpheros

In the Anpheros Daily app, photograph the medicine box: the app reads the name and strength, matches them against this register and adds the medicine to your list, with its code. From your list you can come back to this page.

Get the app

Source: ANMDMR — National Agency for Medicines and Medical Devices of Romania, Nomenclatorul medicamentelor de uz uman (register updated 29 October 2026). Shown as published, in Romanian where the register is in Romanian.